Hebamme 2016; 29(03): 146-148
DOI: 10.1055/s-0042-106709
Aktuelle Diskussion
Impfung in der Schwangerschaft
Hippokrates Verlag in Georg Thieme Verlag KG Stuttgart

Impfung in der Schwangerschaft: kritisch hinterfragt

Michael Friedl
Kinderarzt, Heidelberg
› Author Affiliations
Further Information

Publication History

Publication Date:
30 June 2016 (online)

Impfungen vermitteln ein trügerisches Bild von Sicherheit. Dabei greifen sie gravierend in den gesunden Organismus ein. Und die Liste der mit Impfungen verbundenen Probleme ist lang. Angesichts der Datenlage muss kritisch hinterfragt werden, ob Schwangeren eine Impfung empfohlen werden kann.

 
  • Literatur

  • 1 Ad hoc group for the study of pertussis vaccine. Placebo-controlled trial of two acellular pertussis vaccines in Sweden- protective efficacy and adverse events. Lancet 1988; 1: 955-960
  • 2 Althouse BM, Scarpino SV et al. Asymptomatic transmission and the resurgence of Bordetella pertussis. BMC Medicin 2015; 13: 146
  • 3 Arai M et al. Acute disseminated encephalomyelitis following influenza vaccination: report of a case with callosal disconnection syndrome. Rinsho Shinkeigaku 2014; 54 (2): 135-9
  • 4 Baxter R et al. Effectiveness of pertussis vaccines for adolescents and adults: case-control study. BMJ 2013; 347 f4249
  • 5 Bertilone C et al. Finding the ‚who‘ in whooping cough: vaccinated siblings are important pertussis sources in infants 6 months of age and under. Commun Dis Intell Q Rep 2014; 38 (3): E195-200
  • 6 BGM-Studie summary2014. http://www.bmg.gv.at/home/Aluminium_Toxikologie
  • 7 Castagnini LA, Healy CM et al. Impact of Maternal Postpartum Tetanus and Diphtheria Toxoids and Acellular Pertussis Immunization on Infant Pertussis Infection. Clin Infect Dis 2012; (1): 78-84
  • 8 Choe YJ et al. Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea, 2003–2010. Vaccine 2011; 29 (44): 7727-32
  • 9 Finch NA et al. Guillain-Barré syndrome in an older man following influenza vaccination. J Am Pharm Assoc (2003) 2014; 54 (2): 188-92
  • 10 Fu MH et al. Churg-Strauss Syndrome Following Vaccination Against 2010 Influenza A (H1N1): A Case Report. Acta Neurol Taiwan 2014; 23 (3): 95-101
  • 11 Fujii K et al. Acute disseminated encephalomyelitis following 2009 H1N1 influenza vaccine. Pediatr Int 2012; 54 (4): 539-41
  • 12 Galeotti F et al. Risk of Guillain-Barré syndrome after 2010–2011 influenza vaccination. Eur J Epidemiol 2013; 28 (5): 433-44
  • 13 Geier MR, Geier DA, Zahalsky AC. Influenza vaccination and Guillain Barre syndrome. Clin Immunol 2003; 107: 116-121
  • 14 Hartmann W. Kinder- und Jugendarzt 46. 2015. 4. 15
  • 15 Healy CM et al. Evaluation of the impact of a pertussis cocooning program on infant pertussis infection. Infect Dis J 2015; 34 (1): 22-26
  • 16 Hendrikx LH et al. Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children. Vaccine 2011; 29 (40): 6874-80
  • 17 Ishii K et al. Glossopharyngeal nerve and vagus nerve palsies associated with influenza vaccination. Intern Med 2014; 53 (3): 259-61
  • 18 Jackson ML et al. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet 2008; 372: 398-405
  • 19 Jefferson T. Influenza vaccination: policy versus evidence. BMJ 2006; 333: 912-915
  • 20 Jefferson T. Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis. Cochrane Database Systematic Review. 23 April 2009
  • 21 Jefferson T et al. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2014; 3 CD001269
  • 22 Kawasaki A et al. Bilateral anterior ischemic optic neuropathy following influenza vaccination. J NEUROOPHTHALMOL 1998; 18 (1): 56-9
  • 23 Klein N et al. Kaiser Permanente Study Finds Effectiveness of Routine Tdap Booster Wanes in Adolescents. Pediatrics; 2016
  • 24 Korematsu S et al. Elevated serum anti-phosphatidylcholine IgG antibodies in patients with influenza vaccination-associated optic neuritis. Vaccine 2014; 32 (48): 6345-8
  • 25 Maeda K et al. Acute disseminated encephalomyelitis following 2009 H1N1 influenza vaccination. Intern Med 2012; 51 (14): 1931-3
  • 26 Machicado JD et al. Acute disseminated encephalomyelitis following seasonal influenza vaccination in an elderly patient. Clin Vaccine Immunol 2013; 20 (9): 1485-1486
  • 27 Misegades LK. Estimating the Effectiveness of Acellular Pertussis Vaccines. Clin Infect Dis 2012; 55 (10): 1432-1433 DOI: 10.1093/cid/cis66.
  • 28 Mölling K. Supermacht des Lebens. 2015. C.H.Beck; München: S14–5
  • 29 Nakamura N et al. Neurologic complications associated with influenza vaccination: two adult cases. Intern Med 2003; 42: 191-4
  • 30 Pawloski LC et al. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the US. Clin Vaccine Immunol 2013; DOI: 10.1128/CVI.00717-13.
  • 31 Prestel J et al. Risk of Guillain–Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany. Pharmacoepidemiol Drug Saf 2014; 23 (11): 1192-1204
  • 32 Rizzo C et al. Influenza-related mortality in the Italian elderly: no decline associated with increasing vaccination coverage. Vaccine 2006; 24 (42–43): 6468-75
  • 33 RKI. Pertussis – Stand 2010.
  • 34 RKI. Hinweise für Ärzte zum Aufklärungsbedarf über mögliche unerwünschte Wirkungen bei Schutzimpfungen/Stand: 2007. Epidemiologisches Bulletin 2007; 22 25: 209
  • 35 Rondy M et al. 2012/13 INFLUENZA VACCINE EFFECTIVENESS AGAINST HOSPITALISED INFLUENZA A(H1N1)PDM09, A(H3N2) AND B: ESTIMATES FROM A EUROPEAN NETWORK OF HOSPITALS. Euro Surveill.; 2015 20 (2). pii=21011
  • 36 Sacheli A et al. Influenza vaccine-induced CNS demyelination in a 50-year-old male. Am J Case Rep 2014; 15: 368-73
  • 37 Shoamanesh A. Acute disseminated encephalomyelitis following influenza vaccination Vaccine. 2011; 29 (46): 8182-5
  • 38 Schoenbaum SC, Mostow SR et al. Studies with Inactivated Influenza Vaccines Purified by Zonal Centrifugation. Bull World Health Organ 1969; 41: 531-535
  • 39 Shimizu M et al. Relapse of systemic juvenile idiopathic arthritis after influenza vaccination in a patient receiving tocilizumab. Clin Vaccine Immunol 2012; 19 (10): 1700-2
  • 40 Soriano A Lupus et al. Giant cell arteritis and polymyalgia rheumatica after influenza vaccination: report of 10 cases and review of the literature. 2012; 21 (2): 153-7
  • 41 Souayah N et al. Guillain-Barré syndrome after influenza vaccination in the United States, a report from the CDC/FDA vaccine adverse event reporting system (1990–2009). Neuroepidemiology 2012; 38 (4): 227-32
  • 42 Thomas RE et al. Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions. Cochrane Database Syst Rev 2013; 7 CD005187
  • 43 Turkoglu R et al. Brainstem encephalitis following influenza vaccination: favorable response to steroid treatment. Vaccine 2009; 27 (52): 7253-6
  • 44 Vranjac A. Governo Do Estado Secretaria De Estado Da Saúde, Coordenadoria De Controle De Doenças, Centro De Vigilância Epidemiológica. Informe Técnico Vacina Difteria, Tétano e Coqueluche dTpa. Outubro de 2014
  • 45 Weyerstahl T, Stauber M. Gynäkologie und Geburtshilfe. Georg Thieme Verlag KG Stuttgart; 4. Aufl. 2013
  • 46 WHO. Recommendations for routine immunization.. (Abruf 20.02.2016)